Estuardo Aguilar-Cordova
Fondatore presso CANDEL THERAPEUTICS, INC.
Patrimonio netto: 28 M $ in data 31/05/2024
Posizioni attive di Estuardo Aguilar-Cordova
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CANDEL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2002 | - |
| Fondatore | 01/01/2002 | - | |
| Amministratore Delegato | 01/01/2002 | 01/09/2020 | |
| Direttore Tecnico/Scientifico/R&S | 01/09/2020 | 07/02/2022 |
Storia della carriera di Estuardo Aguilar-Cordova
Precedenti posizioni note di Estuardo Aguilar-Cordova
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Direttore/Membro del Consiglio | - | - |
| Corporate Officer/Principal | - | - |
Formazione di Estuardo Aguilar-Cordova
| California State University-Bakersfield | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
| Universidad Del Valle De Guatemala | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Guatemala | 2 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
Settori
| Consumer Services | 5 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
